Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gaunt

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Lancet. Neurology|January 23, 2016
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trialEmily J Henderson, Stephen R Lord, Matthew A Brodie, et al.
Autism : the International Journal of Research and Practice|November 30, 2019
The feasibility of low-intensity psychological therapy for depression co-occurring with autism in adults: The Autism Depression Trial (ADEPT) - a pilot randomised controlled trialAilsa Russell, Daisy M Gaunt, Kate Cooper, et al.
European Journal of Pediatrics|March 1, 2024
Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trialDaisy M Gaunt, Amberly Brigden, Shaun R S Harris, et al.
BMC Public Health|April 27, 2024
Randomised pilot and feasibility trial of a group intervention for men who perpetrate intimate partner violence against womenHelen Cramer, Daisy M Gaunt, Rebekah Shallcross, et al.
BMC Neurology|October 30, 2021
Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's diseaseS Neumann, J Taylor, A Bamford, et al.
Frontiers in Immunology|August 27, 2021
The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation <i>In Vitro</i>Christopher M Gaunt, Daniel B Rainbow, Ruairi J Mackenzie, et al.
BMJ Open|November 18, 2016
Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary careMatthew J Ridd, Kirsty Garfield, Daisy M Gaunt, et al.
Journal of Animal Science|July 21, 2017
Genetic parameters for wool traits, live weight, and ultrasound carcass traits in Merino sheepS I Mortimer, S Hatcher, N M Fogarty, et al.
Lancet (London, England)|July 3, 2018
Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approachChris Salisbury, Mei-See Man, Peter Bower, et al.
Skin Health and Disease|June 6, 2022
Do patient characteristics matter when calculating sample size for eczema clinical trials?L Howells, S Gran, J R Chalmers, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|January 23, 2016
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trialEmily J Henderson, Stephen R Lord, Matthew A Brodie, et al.
Autism : the International Journal of Research and Practice|November 30, 2019
The feasibility of low-intensity psychological therapy for depression co-occurring with autism in adults: The Autism Depression Trial (ADEPT) - a pilot randomised controlled trialAilsa Russell, Daisy M Gaunt, Kate Cooper, et al.
European Journal of Pediatrics|March 1, 2024
Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trialDaisy M Gaunt, Amberly Brigden, Shaun R S Harris, et al.
BMC Public Health|April 27, 2024
Randomised pilot and feasibility trial of a group intervention for men who perpetrate intimate partner violence against womenHelen Cramer, Daisy M Gaunt, Rebekah Shallcross, et al.
BMC Neurology|October 30, 2021
Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's diseaseS Neumann, J Taylor, A Bamford, et al.
Frontiers in Immunology|August 27, 2021
The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation <i>In Vitro</i>Christopher M Gaunt, Daniel B Rainbow, Ruairi J Mackenzie, et al.
BMJ Open|November 18, 2016
Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary careMatthew J Ridd, Kirsty Garfield, Daisy M Gaunt, et al.
Journal of Animal Science|July 21, 2017
Genetic parameters for wool traits, live weight, and ultrasound carcass traits in Merino sheepS I Mortimer, S Hatcher, N M Fogarty, et al.
Lancet (London, England)|July 3, 2018
Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approachChris Salisbury, Mei-See Man, Peter Bower, et al.
Skin Health and Disease|June 6, 2022
Do patient characteristics matter when calculating sample size for eczema clinical trials?L Howells, S Gran, J R Chalmers, et al.
Pageof 5